BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21069104)

  • 21. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Botulinum toxin A: experience in the treatment of 115 patients].
    Andrade LA; Borges V; Ferraz HB; Azevedo-Silva SM
    Arq Neuropsiquiatr; 1997 Sep; 55(3B):553-7. PubMed ID: 9629404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations.
    Tan EK
    Eur J Neurol; 2006 Feb; 13 Suppl 1():60-4. PubMed ID: 16417600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Idiopathic focal dystonia of the foot in a 98-year-old-woman. Treatment with botulin toxin].
    Verlhac B; Dobigny-Roman N; Forette B
    Presse Med; 1996 Dec; 25(40):2042. PubMed ID: 9082380
    [No Abstract]   [Full Text] [Related]  

  • 26. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Kenney C; Jankovic J
    J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin: historical perspective and potential new indications.
    Jankovic J; Brin MF
    Muscle Nerve Suppl; 1997; 6():S129-45. PubMed ID: 9826986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of laryngeal dystonia with botulinum toxin].
    Olthoff A; Grosheva M; Reichel G; Volk GF; Laskawi R
    Fortschr Neurol Psychiatr; 2017 Aug; 85(8):450-462. PubMed ID: 28841743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia.
    Benninger MS; Gardner G; Grywalski C
    Arch Otolaryngol Head Neck Surg; 2001 Sep; 127(9):1083-5. PubMed ID: 11556856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Movement, visceral and autonomic disorders: use of botulinum toxin.
    Moore AP
    Hosp Med; 2003 Aug; 64(8):452-9. PubMed ID: 12958755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Botulinum toxin injections under electromyographic guidance].
    Bogucki A
    Neurol Neurochir Pol; 1998; 32 Suppl 1():85-93. PubMed ID: 9608557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy with botulinum toxin: harnessing nature's most potent neurotoxin.
    Bell MS; Vermeulen LC; Sperling KB
    Pharmacotherapy; 2000 Sep; 20(9):1079-91. PubMed ID: 10999501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of writer's cramp and other forms of limb dystonias with botulinum toxin].
    Bogucki A
    Neurol Neurochir Pol; 1998; 32 Suppl 1():45-50. PubMed ID: 9608552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commentary: Botulinum toxin in clinical medicine: part II.
    Benedetto AV
    Clin Dermatol; 2004; 22(1):1-2. PubMed ID: 15158537
    [No Abstract]   [Full Text] [Related]  

  • 35. [Laryngeal dystonia].
    Barbosa ER
    Arq Neuropsiquiatr; 2001 Sep; 59(3-B):829. PubMed ID: 11593295
    [No Abstract]   [Full Text] [Related]  

  • 36. Addressing recent concerns in comparative studies of botulinum toxin type A.
    de Boulle K; de Almeida AT
    J Cosmet Laser Ther; 2010 Oct; 12(5):246-8. PubMed ID: 20825255
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients].
    Teive HA; Scola RH; Werneck LC; Quadros Ad ; Gasparetto EL; Sá DS; Brandi IV; Macedo Filho ED
    Arq Neuropsiquiatr; 2001 Mar; 59(1):97-100. PubMed ID: 11299440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Botulinum toxins for pain].
    Soinila S; Haanpää M
    Duodecim; 2011; 127(22):2425-30. PubMed ID: 22238920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Introduction. Botulinum toxin].
    Beylot C; Gassia V
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S53-4. PubMed ID: 19576485
    [No Abstract]   [Full Text] [Related]  

  • 40. Botulinum Toxin Use in the Upper Face.
    Qaqish C
    Atlas Oral Maxillofac Surg Clin North Am; 2016 Sep; 24(2):95-103. PubMed ID: 27499468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.